Delving into the Latest Updates on Connect Biopharma Australia Pty Ltd. with Synapse

A Phase I, Multicenter, Randomized, Double-blind, Double-dummy, Placebo- and Positive-Controlled Study to Investigate the Effects of CBP-307 on the QTc Interval in Healthy Subjects

This study will investigate the effects of therapeutic and supratherapeutic oral doses of CBP-307 on the QTc interval in healthy subjects.

开始日期2021-06-01

申办/合作机构

Connect Biopharma Australia Pty Ltd.

NCT04811469

/ Completed临床1期

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of CBP-174 After Oral Administration

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of CBP-174 after a single oral dose in healthy adult subjects.

开始日期2021-05-24

申办/合作机构

Connect Biopharma Australia Pty Ltd.

ACTRN12619000395134

/ Completed临床1期

A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Pharmacokinetics and Preliminary Efficacy of CBP-201 in Adult Patients with Moderate to Severe Atopic Dermatitis

开始日期2019-05-03

申办/合作机构

Connect Biopharma Australia Pty Ltd.

100 项与 Connect Biopharma Australia Pty Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Connect Biopharma Australia Pty Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Connect Biopharma Australia Pty Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Connect Biopharma Australia Pty Ltd. 相关的转化医学

登录后查看更多信息